BiochemistrybioRxiv
Antibodies generated in vitro and in vivo elucidate design of a thermostable ADDomer COVID-19 nasal nanoparticle vaccine
D. Buzas, H. A. Bunzel, O. Staufer…·I. Berger
This study develops a thermostable ADDomer-based nanoparticle vaccine that neutralizes SARS-CoV-2 and cross-reacts with VOCs, demonstrating its potential for nasal administration.
DOI 10.1093/abt/tbad024